$1.42 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 97 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 30.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARVN | Sell | ARVINAS INC | $45,193,000 | +172.9% | 532,125 | -24.1% | 3.18% | +123.7% |
| PTCT | Sell | PTC THERAPEUTICS INC | $36,861,000 | +17.8% | 603,978 | -9.8% | 2.60% | -3.5% |
| ATRC | Sell | ATRICURE INC | $35,864,000 | +26.8% | 644,217 | -9.1% | 2.53% | +3.9% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $35,434,000 | +16.5% | 1,534,604 | -28.7% | 2.50% | -4.5% |
| EVH | Sell | EVOLENT HEALTH INCcl a | $32,834,000 | +26.8% | 2,048,257 | -1.8% | 2.31% | +4.0% |
| RCM | Sell | R1 RCM INC | $28,209,000 | +6.8% | 1,174,393 | -23.8% | 1.99% | -12.5% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $24,590,000 | -19.8% | 320,059 | -21.9% | 1.73% | -34.3% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $22,356,000 | +41.3% | 861,160 | -6.7% | 1.58% | +15.8% |
| DXCM | Sell | DEXCOM INC | $15,699,000 | -21.3% | 42,463 | -12.3% | 1.11% | -35.5% |
| CNC | Sell | CENTENE CORP DEL | $15,399,000 | -32.3% | 256,515 | -34.2% | 1.08% | -44.5% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $15,401,000 | -30.1% | 389,006 | -38.6% | 1.08% | -42.7% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $15,308,000 | -44.0% | 136,500 | -53.7% | 1.08% | -54.1% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $14,769,000 | +14.0% | 86,624 | -6.1% | 1.04% | -6.6% |
| RMD | Sell | RESMED INC | $14,094,000 | +13.7% | 66,305 | -8.3% | 0.99% | -6.8% |
| MRNA | Sell | MODERNA INC | $13,195,000 | +37.2% | 126,306 | -7.1% | 0.93% | +12.5% |
| FRLN | Sell | FREELINE THERAPEUTICS HLDGSsponsored ads | $12,006,000 | -8.7% | 657,494 | -22.0% | 0.85% | -25.2% |
| PODD | Sell | INSULET CORP | $10,904,000 | +3.2% | 42,654 | -4.5% | 0.77% | -15.4% |
| GH | Sell | GUARDANT HEALTH INC | $10,180,000 | +13.3% | 78,986 | -1.7% | 0.72% | -7.2% |
| PSTX | Sell | POSEIDA THERAPETUICS INC | $9,202,000 | -1.6% | 838,826 | -20.4% | 0.65% | -19.4% |
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $9,030,000 | -24.2% | 145,574 | -26.3% | 0.64% | -37.9% |
| CTSO | Sell | CYTOSORBENTS CORP | $8,806,000 | -32.3% | 1,104,935 | -32.2% | 0.62% | -44.5% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $8,486,000 | -26.3% | 96,772 | -36.0% | 0.60% | -39.6% |
| MOH | Sell | MOLINA HEALTHCARE INC | $8,076,000 | -22.9% | 37,972 | -33.7% | 0.57% | -36.8% |
| CMPI | Sell | CHECKMATE PHARMACEUTICALS IN | $8,007,000 | +15.8% | 548,802 | -8.6% | 0.56% | -5.1% |
| AMGN | Sell | AMGEN INC | $5,162,000 | -16.6% | 22,453 | -7.8% | 0.36% | -31.6% |
| MDT | Sell | MEDTRONIC PLC | $4,510,000 | +3.9% | 38,501 | -7.8% | 0.32% | -14.7% |
| MRK | Sell | MERCK & CO. INC | $3,640,000 | -13.1% | 44,500 | -11.9% | 0.26% | -28.6% |
| PFE | Sell | PFIZER INC | $3,493,000 | -15.0% | 94,900 | -15.2% | 0.25% | -30.3% |
| BIIB | Sell | BIOGEN INC | $3,130,000 | -51.2% | 12,782 | -43.5% | 0.22% | -60.0% |
| REGN | Sell | REGENERON PHARMCTICALS | $2,232,000 | -82.6% | 4,620 | -79.9% | 0.16% | -85.8% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $1,806,000 | -87.5% | 50,226 | -86.7% | 0.13% | -89.7% |
| GILD | Sell | GILEAD SCIENCES INC | $1,722,000 | -58.0% | 29,550 | -54.5% | 0.12% | -65.7% |
| ILMN | Sell | ILLUMINA INC | $1,506,000 | +0.6% | 4,070 | -16.0% | 0.11% | -17.8% |
| APRE | Sell | APREA THERAPEUTICS INC | $805,000 | -96.3% | 163,681 | -82.1% | 0.06% | -97.0% |
| INCY | Sell | INCYTE CORP | $752,000 | -94.0% | 8,640 | -93.8% | 0.05% | -95.1% |
| ALVR | Sell | ALLOVIR INC | $375,000 | -95.1% | 9,746 | -96.5% | 0.03% | -96.0% |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -18,500 | -100.0% | -0.08% | – |
| GBIO | Exit | GENERATION BIO CO | $0 | – | -35,000 | -100.0% | -0.09% | – |
| HUM | Exit | HUMANA INC | $0 | – | -2,666 | -100.0% | -0.10% | – |
| CHNG | Exit | CHANGE HEALTHCARE INC | $0 | – | -82,145 | -100.0% | -0.10% | – |
| TRHC | Exit | TABULA RASA HEALTHCARE INC | $0 | – | -35,177 | -100.0% | -0.12% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -69,773 | -100.0% | -0.30% | – |
| AMED | Exit | AMEDISYS INC | $0 | – | -15,825 | -100.0% | -0.32% | – |
| EBS | Exit | EMERGENT BIOSOLUTIONS INC | $0 | – | -79,950 | -100.0% | -0.71% | – |
| TSHA | Exit | TAYSHA GENE THERAPIES INC | $0 | – | -373,775 | -100.0% | -0.72% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -474,301 | -100.0% | -0.82% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -54,716 | -100.0% | -0.92% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -255,271 | -100.0% | -1.21% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -916,185 | -100.0% | -1.30% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -556,712 | -100.0% | -1.56% | – |
| HMSY | Exit | HMS HLDGS CORP | $0 | – | -782,563 | -100.0% | -1.61% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -600,242 | -100.0% | -4.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.